Annals of Hematology

Article	Citations
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	61
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	58
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	53
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	51
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	46
Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma	37
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome	34
Second allogeneic transplantation in relapsed acute leukemia – a risk worth taking?	33
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score	33
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	32
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	32
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis	31
Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis	30
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature	29
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	26
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	26
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	24
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates	24
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification	24
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome	23
Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics	22
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	21
Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies	21
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts	21
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16–19, 2025	21

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	20
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	20
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multipl	20
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	20
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	19
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	19
Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea	19
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	18
T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults	18
Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis	18
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma	18
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	18
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	17
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	17
“In situ” MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration	17
Clinical profile and treatment outcomes in paediatric and adult acute promyelocytic leukemia: experience from a tertiary care centre in Northern India	17
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	17
Advances in the ocular complications after hematopoietic stem cell transplantation	17
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	16
Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis	16
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials	16
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	16
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	16
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	16
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis	16
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	16
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade	16
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	15
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews	15
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience	15
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs	15
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	15
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	15
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study	15
Post-transplant lymphoproliferative disease of two different histological types	15
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials	15
Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia	15
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p	15
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry	14
Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)	14
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Inf	14
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture	14
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria	14
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma	14
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma	14
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome	14
TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia	13
Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis	13
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study	13
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland	13

Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review	13
A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report	13
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)	13
A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results	13
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies	13
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?	13
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab	13
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial	12
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab	12
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics	12
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia	12
Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children	12
Optimal dosage of rituximab for children with Burkitt lymphoma	12
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes	12
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia	12
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report	12
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia	12
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment	12
Safety and efficacy of daratumumab in Chinese patients with relapsed or refractory multiple myeloma: a phase 1, dose-escalation study (MMY1003)	12
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study	12
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes	12
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation	12
Interim PET in follicular lymphoma: more patience, please	11
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective	11
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?	11
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms	11
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors	11
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database	11
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report	11
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis	11
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?	11
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation	11
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs	11
The roles of ubiquitination in AML	11
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment	11
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases	11
Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis	11
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report	11
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients	11
A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate	11
Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma	10
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study	10
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report	10
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century	10
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical review	10
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes	10
Challenges in accuracy in molecular genetic diagnosis of childhood AML: case series	10
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood	10
Tandem autologous hematopoietic stem cell transplantation in multiple myeloma: A historical perspective and current challenges	10
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience	10
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)	10
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report	10
Validity of the criteria for clinical transformation of follicular lymphoma: analysis of a mostly biopsied cohort	10
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation	10
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience	10
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use	10
An unexpected find of multifocal extranodal marginal zone lymphoma	10
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial	10
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia	10
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases	10
Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia	10
Analytical considerations affecting plasma free haemoglobin, the haemolysis index, and correlation with clinical outcomes in sickle cell disease	10
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Cen	10
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia	10
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study	10
The experience of diagnosis and treatment for TAFRO syndrome	10
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis	10
Prognostic value of laboratory biomarkers for mortality risk stratification in thrombotic thrombocytopenic purpura	10
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis	9
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL	9
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey	9
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency	9
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed	9
Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center	9
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?	9
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome	9
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study	9
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population	9
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia	9
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma	9

Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma	9
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia	9
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation	9
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study	9
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments	9
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice	9
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma	9
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings	9
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine	9
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia	9
Hemolytic anemia in COVID-19	9
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations	9
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders	9
Romiplostim versus Recombinant human thrombopoietin in umbilical cord blood transplantation: a single-center retrospective study	9
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma	9
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020	9
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia	9
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma	9
A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1	9
A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation	9
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia	9
Clinical features and outcomes in large granular lymphocyte leukemia − associated pure red cell aplasia with STAT3 mutation	9
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia	9
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China	8
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran	8
Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients	8
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort	8
Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes	8
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide	8
Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement	8
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL	8
Broadening perspectives: redefining the role of obesity in ITP	8
A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study	8
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia	8
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory	8
Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia	8
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia	8
Rhabdomyolysis induced by nelarabine	8
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study	8
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement	8
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians	8
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group	8
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP	8
Sickle cell disease and acute leukemia: one case report and an extensive review	8
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	8
Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients	8
Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabru	8
Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab	8
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China	8
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia	8
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry	8
A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype	8
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives	8
Clinical features and fusion gene analysis of two Torque Teno Mini virus associated acute promyelocytic leukemia cases	8
L-DEP regimen is effective as an initial therapy for adult EBV-HLH	8
A case report of dyskeratosis congenita caused by a novel TERC mutation	8
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management	8
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group	8
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study	8
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA	8
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma	8
Recent advances in CD5+ diffuse large B-cell lymphoma	8
Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample	8
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)	8
Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia	8
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study	8
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma	7
Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploiden	7
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group	7
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study	7
Response to daratumumab-retreatment in patients with multiple myeloma	7
Distinct structural and numerical chromosome abnormalities determine the MYC status in diffuse large B-Cell lymphoma and help differentiate from Burkitt lymphoma: a cytogenetic data analysis using uns	7
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience	7
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma	7
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United St	7
Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease	7
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China	7
Predictors for spontaneous remission in childhood chronic immune thrombocytopenia	7
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study	7
A cross-sectional survey on health care professionals’ approaches, challenges, and support needs when addressing life threat with recipients of an allogeneic hematopoietic stem cell transplantation an	7
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome	7
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a	7
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course	7
Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant	7
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma	7
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma	7
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients	7
Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia	7
Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices	7
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia	7
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies	7
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	7
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group	7
Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience	7
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis	7